These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9203190

  • 21. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R, Obialo CI, Rothstein M.
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
    Montini G, Zacchello G, Perfumo F, Edefonti A, Bassi S, Cantaluppi A, Sarchi C, Cazzin M, Ferrari V, Boccazzi A.
    J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Feb; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis.
    Belsha CW, Berry PL.
    Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis.
    Sharples EJ, Varagunam M, Sinnott PJ, McCloskey DJ, Raftery MJ, Yaqoob MM.
    Perit Dial Int; 2006 May; 26(1):64-8. PubMed ID: 16538877
    [Abstract] [Full Text] [Related]

  • 35. A multicenter study with once a week or once every two weeks high-dose subcutaneous administration of recombinant human erythropoietin in continuous ambulatory peritoneal dialysis.
    Nomoto Y, Kawaguchi Y, Kubota M, Tagawa H, Kubo K, Ogura Y, Shoji T, Kawada Y, Koshikawa S, Mimura N.
    Perit Dial Int; 1994 May; 14(1):56-60. PubMed ID: 8312416
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H, Kanno Y, Okada H, Suzuki H.
    Adv Perit Dial; 2004 May; 20():111-6. PubMed ID: 15384808
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly.
    Frifelt JJ, Tvedegaard E, Bruun K, Steffensen G, Cintin C, Breddam M, Dominguez H, Jørgensen JD.
    Perit Dial Int; 1996 May; 16(6):594-8. PubMed ID: 8981527
    [Abstract] [Full Text] [Related]

  • 39. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 May; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 40. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
    Zappacosta AR, Perras ST, Bell A.
    Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.